CDH1, cadherin 1, 999

N. diseases: 508; N. variants: 187
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 Biomarker disease BEFREE <i>SNAI1</i> mRNA levels strongly correlated with the expression of CCA markers, including SOX9, CK19, and EPCAM, but not with EMT markers such as E-CADHERIN and ZO-1, in human HCC samples. 31383647 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 Biomarker disease BEFREE Taken together, our study presents the regulation mechanism of miR-101/ZNF217/CDH1 axis for the first time and provides new evidences of ZNF217 as a potential therapeutic target for HCC patients. 30898548 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 AlteredExpression disease BEFREE The level of TRERNA1 was positively correlated with tumour metastasis and was negatively correlated with the expression of CDH1 in HCC tissues. 31012192 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 AlteredExpression disease BEFREE In addition, the upregulation of HDAC6 inhibited the epithelial-to-mesenchymal transition in HCC by increasing the E-cadherin protein levels and decreasing the N-cadherin, vimentin and matrix metalloproteinase-9 protein levels. 30546442 2018
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 Biomarker disease BEFREE In conclusion, miR-219-5p promotes tumor growth and metastasis of HCC by regulating CDH1 and can serve as a prognostic marker for HCC patients. 29862272 2018
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 AlteredExpression disease BEFREE These data clearly show that ARHGAP9/FOXJ2 inhibit cell migration and invasion during HCC development via inducing the transcription of CDH1. 30206221 2018
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 PosttranslationalModification disease BEFREE E-cadherin (CDH1) hypermethylation was observed to be significantly higher in HCC than in benign, adjacent, or normal samples. 28422868 2017
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 Biomarker disease BEFREE Aberrant sera DNA methylation of CDH1, DNMT3b and ESR1 gene promoters could be a biomarker in the early diagnosis of HBV-related HCC. 26660680 2016
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 AlteredExpression disease BEFREE PPARA and CDH1 mRNA levels were decreased in HCC relative to controls and were inversely correlated with miR-9 levels. 26206264 2015
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 AlteredExpression disease BEFREE In addition, ARID1A and E-cadherin (CDH1) expression were found to be regulated in a coordinated fashion in HCC samples. 25975202 2015
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 AlteredExpression disease BEFREE Furthermore, our results show that MTBP and E-cadherin protein expression are inversely correlated in primary HCC tissues. 26280083 2015
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 Biomarker disease BEFREE Time course analysis of invasion/metastasis gene expressions (MMP2, MMP7, MMP9, CD44, SPP1, CXCR4, CXCL12, and CDH1) showed remarkable, dynamic alterations during the invasion process of HCC. 24614035 2014
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 AlteredExpression disease BEFREE Linear regression analysis revealed a positive correlation between the expression of miR-148a and the mRNA level of E-cadherin gene in human HCC tissues. 24013226 2014
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 AlteredExpression disease BEFREE In addition, KLF8, FAK, MMP‑9 and E‑cadherin protein expression levels were examined by western blot analysis in 5 portal vein cancer emboli and corresponding HCC tissues. 23670717 2013
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 AlteredExpression disease BEFREE Interestingly, the up-regulation of EZH2, CTNNB1 and the down-regulation of CDH1 in HCC patients correlated with early recurrent disease and can be an independent predictor of poor survival. 22962603 2012
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 PosttranslationalModification disease BEFREE In this study, we showed that CDH1 promoter was hypermethylated in drug resistance of a doxorubicin-induced multidrug resistant hepatocellular carcinoma cell line R-HepG2. 22634315 2012
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 GeneticVariation disease BEFREE After adjusting for other confounders, results show that individuals with the CDH1-347G/GA or GA/GA polymorphic genotypes had a significantly higher risk of developing HCC than those with the wild-type (G/G) genotype (adjusted odds ratio = 2.477; 95%CI: 1.421-4.319). 21462191 2011
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 Biomarker disease BEFREE In contrast to common HCC the APC and CDH1 (E-cadherin) genes were found devoid of any DNA methylation in FLC, whereas the GSTπ1 gene showed comparable DNA methylation in tumor and surrounding tissue at a moderate level. 21060828 2010
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 AlteredExpression disease BEFREE Knockdown of thrombomodulin enhances HCC cell migration through increase of ZEB1 and decrease of E-cadherin gene expression. 20625840 2010
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 PosttranslationalModification disease BEFREE ROS-induced stress, E-cadherin expression, Snail expression, and E-cadherin promoter methylation were confirmed in HCC tissues by immunoblot, immunohistochemistry, and methyl-specific polymerase chain reaction analyses. 18801366 2008
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 Biomarker disease BEFREE We retrospectively analyzed CpG island hypermethylation of the p14, p15, p16, GSTP1, integrin alpha4, SYK, and CDH1 genes in fresh-frozen tissues from 265 patients with hepatocellular carcinoma using the methylation-specific PCR. 18723830 2008
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 AlteredExpression disease LHGDN Expression of E- and N-cadherin and clinicopathology in hepatocellular carcinoma. 18801083 2008
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 AlteredExpression disease LHGDN Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma. 18842495 2008
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 PosttranslationalModification disease BEFREE DNA methyltransferase 1 knockdown induces silenced CDH1 gene reexpression by demethylation of methylated CpG in hepatocellular carcinoma cell line SMMC-7721. 18049164 2007
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 Biomarker disease RGD CpG site hypermethylation of E-cadherin and Connexin26 genes in hepatocellular carcinomas induced by a choline-deficient L-Amino Acid-defined diet in rats. 17295234 2007